Reduction in exacerbations with mepolizumab in severe eosinophilic asthma: MENSA study

被引：0
|
作者：
Ortega, Hector
Liu, Mark
Pavord, Ian
Brusselle, Guy
FitzGerald, J. Mark
Chetta, Alfredo
Katz, Lynn
Keene, Oliver
Yancey, Steven
Chanez, Pascal
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Exacerbation; Asthma; -; management; Inflammation;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2906
引用
收藏
页数：4
相关论文
共 50 条
  • [31] IMPACT OF WEIGHT ON STEROID REDUCTION IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA TREATED WITH MEPOLIZUMAB
    Katial, R.
    Albers, F.
    Prazma, C.
    Bradford, E.
    Ortega, H.
    Price, R.
    Pouliquen, I.
    Castro, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : E3 - E3
  • [32] Asthma Control In Patients With Severe Eosinophilic Asthma Treated With Mepolizumab
    Llanos-Ackert, J. -P.
    Price, R. G.
    Forshag, M.
    Yancey, S.
    Liu, M. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [33] Effectiveness of mepolizumab in patients with severe eosinophilic asthma: In a real life study
    Bulut, Ismet
    Katran, Zeynep Yegin
    Yavuz, Dilek
    Akyildiz, Ali Burkan
    Yakut, Tugce
    Orcen, Cihan
    Mersin, Selver Seda
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2023, 71 (02): : 148 - 155
  • [34] EFFICACY AND SAFETY OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA: A REAL LIFE STUDY
    Mitchell, V.
    Howles, K.
    Mansur, A. H.
    THORAX, 2018, 73 : A125 - A125
  • [35] Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study
    Lorenza Vantaggiato
    Marco Perruzza
    Rosa Metella Refini
    Laura Bergantini
    Miriana d’Alessandro
    Paolo Cameli
    Davide Perruzza
    Luca Bini
    Elena Bargagli
    Claudia Landi
    Lung, 2020, 198 : 761 - 765
  • [36] Efficacy of mepolizumab in reducing exacerbations in patients with severe eosinophilic asthma who would be eligible for omalizumab treatment
    Albers, F. C.
    Price, R. G.
    Yancey, S. W.
    Bradford, E.
    ALLERGY, 2016, 71 : 66 - 67
  • [37] Mepolizumab and Benralizumab in Severe Eosinophilic Asthma: Preliminary Results of a Proteomic Study
    Vantaggiato, Lorenza
    Perruzza, Marco
    Refini, Rosa Metella
    Bergantini, Laura
    D'Alessandro, Miriana
    Cameli, Paolo
    Perruzza, Davide
    Bini, Luca
    Bargagli, Elena
    Landi, Claudia
    LUNG, 2020, 198 (05) : 761 - 765
  • [38] Mepolizumab improves activity limitation in severe eosinophilic asthma
    Albers, Frank
    Nelsen, Linda M.
    Bratton, Daniel J.
    Bradford, Eric S.
    Braunstahl, G. J.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [39] Oscillometry in severe eosinophilic asthma commencing mepolizumab or benralizumab
    Fernando, M.
    Jeffrey, B.
    Tierney, C.
    Seccombe, L.
    Peters, M.
    Farah, C.
    Cottee, A.
    RESPIROLOGY, 2023, 28 : 81 - 81
  • [40] CLINICAL RESPONSE TO MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Harvey, E.
    Langton, D.
    Powell, H.
    Gibson, P.
    RESPIROLOGY, 2019, 24 : 42 - 42
12345